Important health debate from The Economist [link].
"This house believes that the widespread use of comparative effectiveness reviews and cost/benefit analyses will stifle medical innovation and lead to an unacceptable rationing of health care."
Defending the motion - Newt Gingrich
Former Speaker of the U.S. House of Representatives and Founder, Center for Health Transformation
Against the motion - Sir Michael Rawlins
Chairman, National Institute for Health and Clinical Excellence (NICE)
My vote is for Sir Michael Rawlins.
Tags: Comparative Effectiveness Reviews - Cost-Benefit Analysis - Health Care - Medical Innovation - Michael Rawlins - Newt Ginrich - Rationing
Posted by the ALCHEssMIST-Alchemipedia-Cetacographer alliance.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment